Achieve Life Sciences Inc. (ACHV) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Achieve Life Sciences Inc...

    NASDAQ: ACHV · Real-Time Price · USD
    3.15
    -0.04 (-1.25%)
    At close: Oct 03, 2025, 3:59 PM
    3.11
    -1.22%
    After-hours: Oct 03, 2025, 07:42 PM EDT

    Achieve Life Sciences Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -39.83M -29.82M -42.35M -33.15M
    Depreciation & Amortization
    		 229K 228K 236K 250K
    Stock-Based Compensation
    		 5.33M 3.44M 3.27M 2.19M
    Other Working Capital
    		 969K 264K -720K 725K
    Other Non-Cash Items
    		 2.09M 2.45M 1.2M 41K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 2.41M -778K 99K 1.23M
    Operating Cash Flow
    		 -29.77M -24.48M -37.55M -29.44M
    Capital Expenditures
    		 n/a -21K n/a -17K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -47.89M n/a n/a n/a
    Sales Maturities Of Investments
    		 26.31M n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -21.58M -21K n/a -17K
    Debt Repayment
    		 -8.29M n/a n/a 14.93M
    Common Stock Repurchased
    		 n/a -30K n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 746K 7K 103K 338K
    Financial Cash Flow
    		 48.53M 15.28M 19.3M 36.61M
    Net Cash Flow
    		 -2.82M -9.22M -18.25M 7.17M
    Free Cash Flow
    		 -29.77M -24.5M -37.55M -29.46M

    Add to Watchlist